Global Medical Radioactive Microspheres Market Growth 2026-2032
The global Medical Radioactive Microspheres market size is predicted to grow from US$ 208 million in 2025 to US$ 444 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032.
Medical radioactive microspheres are a type of radioactive embolic agent that uses interventional means to inject micron-sized particles (usually 20-45 microns in diameter) containing radionuclides (such as yttrium [90Y]) into the tumor's blood supply artery. The carrier material is mostly ceramic, resin or glass. It releases beta rays through targeted tumors (to kill tumor cells at close range, and at the same time has the function of embolizing blood vessels, which can significantly improve the local control rate of tumors and reduce normal tissue damage. It is mainly used clinically for the treatment of solid tumors such as primary liver cancer and colorectal cancer liver metastasis that cannot be surgically removed. It has the advantages of high targeting, few side effects, and reliable efficacy, and can meet individualized treatment needs through customized personalized activity.
Future development trends, driving factors and obstacles of medical radioactive microspheres
Application field expansion
At present, medical radioactive microspheres are mainly used for liver cancer treatment, but in the future they are expected to be expanded to the treatment of other malignant tumors such as pancreatic cancer, bladder cancer, head and neck cancer, etc. In addition, with the advancement of technology, radioactive microspheres may play a greater role in the treatment of benign diseases.
Technological innovation and product upgrade
The preparation technology of radioactive microspheres will continue to be optimized, such as developing microspheres with smaller particle size and more uniform distribution to improve the treatment effect and reduce side effects. At the same time, the research on visual microspheres will promote the development of real-time monitoring technology, enabling doctors to control the distribution and dosage of microspheres more accurately.
Intensified market competition
As market demand grows, more and more companies will enter the field of medical radioactive microspheres, and market competition will become more intense. At present, major global manufacturers include Sirtex Medical and Boston Scientific Corporation, and more new players may emerge in the future.
Development drivers
Increasing cancer incidenc
The global cancer incidence rate is increasing year by year, especially malignant tumors such as liver cancer. According to the World Health Organization, liver cancer is the sixth most common cancer in the world and the third leading cause of cancer death. As an effective local treatment method, the market demand for radioactive microspheres will continue to grow.
Technological progress
The preparation technology and application technology of radioactive microspheres are constantly improving. For example, the research and application of yttrium [90Y] microspheres make treatment more accurate and safe. In addition, the research on visualized microspheres will further improve the controllability and effect of treatment.
Policy support
Governments of various countries have continuously increased their support for medical technology, especially in the field of cancer treatment. For example, China has introduced a series of policies to support the development of biopharmaceuticals and traditional Chinese medicine industries, and promote the industrialization of technologies such as sustained-release preparations and targeted preparations.
Development obstacles
Technical barriers
The preparation technology of medical radioactive microspheres is complex and requires high-precision equipment and processes. At present, domestic companies still have a certain gap in microsphere preparation technology, relying on imported materials and equipment, which increases production costs and supply chain uncertainty.
Market competition and price pressure
With the intensification of market competition, price pressure will increase. How to reduce production costs and improve market competitiveness while ensuring product quality and efficacy is a challenge faced by companies.
Regulation and approval
As medical devices, medical radioactive microspheres need to undergo strict supervision and approval. Different regulatory requirements in different countries and regions increase the difficulty and time cost of bringing products to market.
LP Information, Inc. (LPI) ' newest research report, the ?Medical Radioactive Microspheres Industry Forecast? looks at past sales and reviews total world Medical Radioactive Microspheres sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Radioactive Microspheres sales for 2026 through 2032. With Medical Radioactive Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Radioactive Microspheres industry.
This Insight Report provides a comprehensive analysis of the global Medical Radioactive Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Radioactive Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Medical Radioactive Microspheres market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Radioactive Microspheres and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Radioactive Microspheres.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Radioactive Microspheres market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Medical Radioactive Microspheres market?
What factors are driving Medical Radioactive Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Radioactive Microspheres market opportunities vary by end market size?
How does Medical Radioactive Microspheres break out by Type, by Application?
Medical radioactive microspheres are a type of radioactive embolic agent that uses interventional means to inject micron-sized particles (usually 20-45 microns in diameter) containing radionuclides (such as yttrium [90Y]) into the tumor's blood supply artery. The carrier material is mostly ceramic, resin or glass. It releases beta rays through targeted tumors (to kill tumor cells at close range, and at the same time has the function of embolizing blood vessels, which can significantly improve the local control rate of tumors and reduce normal tissue damage. It is mainly used clinically for the treatment of solid tumors such as primary liver cancer and colorectal cancer liver metastasis that cannot be surgically removed. It has the advantages of high targeting, few side effects, and reliable efficacy, and can meet individualized treatment needs through customized personalized activity.
Future development trends, driving factors and obstacles of medical radioactive microspheres
Application field expansion
At present, medical radioactive microspheres are mainly used for liver cancer treatment, but in the future they are expected to be expanded to the treatment of other malignant tumors such as pancreatic cancer, bladder cancer, head and neck cancer, etc. In addition, with the advancement of technology, radioactive microspheres may play a greater role in the treatment of benign diseases.
Technological innovation and product upgrade
The preparation technology of radioactive microspheres will continue to be optimized, such as developing microspheres with smaller particle size and more uniform distribution to improve the treatment effect and reduce side effects. At the same time, the research on visual microspheres will promote the development of real-time monitoring technology, enabling doctors to control the distribution and dosage of microspheres more accurately.
Intensified market competition
As market demand grows, more and more companies will enter the field of medical radioactive microspheres, and market competition will become more intense. At present, major global manufacturers include Sirtex Medical and Boston Scientific Corporation, and more new players may emerge in the future.
Development drivers
Increasing cancer incidenc
The global cancer incidence rate is increasing year by year, especially malignant tumors such as liver cancer. According to the World Health Organization, liver cancer is the sixth most common cancer in the world and the third leading cause of cancer death. As an effective local treatment method, the market demand for radioactive microspheres will continue to grow.
Technological progress
The preparation technology and application technology of radioactive microspheres are constantly improving. For example, the research and application of yttrium [90Y] microspheres make treatment more accurate and safe. In addition, the research on visualized microspheres will further improve the controllability and effect of treatment.
Policy support
Governments of various countries have continuously increased their support for medical technology, especially in the field of cancer treatment. For example, China has introduced a series of policies to support the development of biopharmaceuticals and traditional Chinese medicine industries, and promote the industrialization of technologies such as sustained-release preparations and targeted preparations.
Development obstacles
Technical barriers
The preparation technology of medical radioactive microspheres is complex and requires high-precision equipment and processes. At present, domestic companies still have a certain gap in microsphere preparation technology, relying on imported materials and equipment, which increases production costs and supply chain uncertainty.
Market competition and price pressure
With the intensification of market competition, price pressure will increase. How to reduce production costs and improve market competitiveness while ensuring product quality and efficacy is a challenge faced by companies.
Regulation and approval
As medical devices, medical radioactive microspheres need to undergo strict supervision and approval. Different regulatory requirements in different countries and regions increase the difficulty and time cost of bringing products to market.
LP Information, Inc. (LPI) ' newest research report, the ?Medical Radioactive Microspheres Industry Forecast? looks at past sales and reviews total world Medical Radioactive Microspheres sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Radioactive Microspheres sales for 2026 through 2032. With Medical Radioactive Microspheres sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Radioactive Microspheres industry.
This Insight Report provides a comprehensive analysis of the global Medical Radioactive Microspheres landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Radioactive Microspheres portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Medical Radioactive Microspheres market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Radioactive Microspheres and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Radioactive Microspheres.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Radioactive Microspheres market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Holmium-166 Microspheres
- Yttrium-90 Microspheres
- Cancer Treatment
- Diagnosis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- New Radiomedicine Technology
- Grand Pharmaceutical Group Limited
- YH Nu-Med
- Boston Scientific
- Sirtex Medical Limited
- Terumo
- ABK Biomedical
- AtomVie
- BWXT Medical
What is the 10-year outlook for the global Medical Radioactive Microspheres market?
What factors are driving Medical Radioactive Microspheres market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Radioactive Microspheres market opportunities vary by end market size?
How does Medical Radioactive Microspheres break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Radioactive Microspheres Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Radioactive Microspheres by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Radioactive Microspheres by Country/Region, 2021, 2025 & 2032
2.2 Medical Radioactive Microspheres Segment by Type
2.2.1 Holmium-166 Microspheres
2.2.2 Yttrium-90 Microspheres
2.2.3 Medical Radioactive Microspheres Sales by Type
2.2.3.1 Global Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
2.2.3.2 Global Medical Radioactive Microspheres Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Medical Radioactive Microspheres Sale Price by Type (2021-2026)
2.3 Medical Radioactive Microspheres Segment by Application
2.3.1 Cancer Treatment
2.3.2 Diagnosis
2.3.3 Others
2.3.4 Medical Radioactive Microspheres Sales by Application
2.3.4.1 Global Medical Radioactive Microspheres Sale Market Share by Application (2021-2026)
2.3.4.2 Global Medical Radioactive Microspheres Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Medical Radioactive Microspheres Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Radioactive Microspheres Breakdown Data by Company
3.1.1 Global Medical Radioactive Microspheres Annual Sales by Company (2021-2026)
3.1.2 Global Medical Radioactive Microspheres Sales Market Share by Company (2021-2026)
3.2 Global Medical Radioactive Microspheres Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Radioactive Microspheres Revenue by Company (2021-2026)
3.2.2 Global Medical Radioactive Microspheres Revenue Market Share by Company (2021-2026)
3.3 Global Medical Radioactive Microspheres Sale Price by Company
3.4 Key Manufacturers Medical Radioactive Microspheres Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Radioactive Microspheres Product Location Distribution
3.4.2 Players Medical Radioactive Microspheres Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL RADIOACTIVE MICROSPHERES BY GEOGRAPHIC REGION
4.1 World Historic Medical Radioactive Microspheres Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Radioactive Microspheres Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Radioactive Microspheres Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Radioactive Microspheres Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Radioactive Microspheres Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Radioactive Microspheres Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Radioactive Microspheres Sales Growth
4.4 APAC Medical Radioactive Microspheres Sales Growth
4.5 Europe Medical Radioactive Microspheres Sales Growth
4.6 Middle East & Africa Medical Radioactive Microspheres Sales Growth
5 AMERICAS
5.1 Americas Medical Radioactive Microspheres Sales by Country
5.1.1 Americas Medical Radioactive Microspheres Sales by Country (2021-2026)
5.1.2 Americas Medical Radioactive Microspheres Revenue by Country (2021-2026)
5.2 Americas Medical Radioactive Microspheres Sales by Type (2021-2026)
5.3 Americas Medical Radioactive Microspheres Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Radioactive Microspheres Sales by Region
6.1.1 APAC Medical Radioactive Microspheres Sales by Region (2021-2026)
6.1.2 APAC Medical Radioactive Microspheres Revenue by Region (2021-2026)
6.2 APAC Medical Radioactive Microspheres Sales by Type (2021-2026)
6.3 APAC Medical Radioactive Microspheres Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Radioactive Microspheres by Country
7.1.1 Europe Medical Radioactive Microspheres Sales by Country (2021-2026)
7.1.2 Europe Medical Radioactive Microspheres Revenue by Country (2021-2026)
7.2 Europe Medical Radioactive Microspheres Sales by Type (2021-2026)
7.3 Europe Medical Radioactive Microspheres Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Radioactive Microspheres by Country
8.1.1 Middle East & Africa Medical Radioactive Microspheres Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Radioactive Microspheres Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Radioactive Microspheres Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Radioactive Microspheres Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Radioactive Microspheres
10.3 Manufacturing Process Analysis of Medical Radioactive Microspheres
10.4 Industry Chain Structure of Medical Radioactive Microspheres
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Radioactive Microspheres Distributors
11.3 Medical Radioactive Microspheres Customer
12 WORLD FORECAST REVIEW FOR MEDICAL RADIOACTIVE MICROSPHERES BY GEOGRAPHIC REGION
12.1 Global Medical Radioactive Microspheres Market Size Forecast by Region
12.1.1 Global Medical Radioactive Microspheres Forecast by Region (2027-2032)
12.1.2 Global Medical Radioactive Microspheres Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Radioactive Microspheres Forecast by Type (2027-2032)
12.7 Global Medical Radioactive Microspheres Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 New Radiomedicine Technology
13.1.1 New Radiomedicine Technology Company Information
13.1.2 New Radiomedicine Technology Medical Radioactive Microspheres Product Portfolios and Specifications
13.1.3 New Radiomedicine Technology Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 New Radiomedicine Technology Main Business Overview
13.1.5 New Radiomedicine Technology Latest Developments
13.2 Grand Pharmaceutical Group Limited
13.2.1 Grand Pharmaceutical Group Limited Company Information
13.2.2 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Product Portfolios and Specifications
13.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Grand Pharmaceutical Group Limited Main Business Overview
13.2.5 Grand Pharmaceutical Group Limited Latest Developments
13.3 YH Nu-Med
13.3.1 YH Nu-Med Company Information
13.3.2 YH Nu-Med Medical Radioactive Microspheres Product Portfolios and Specifications
13.3.3 YH Nu-Med Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 YH Nu-Med Main Business Overview
13.3.5 YH Nu-Med Latest Developments
13.4 Boston Scientific
13.4.1 Boston Scientific Company Information
13.4.2 Boston Scientific Medical Radioactive Microspheres Product Portfolios and Specifications
13.4.3 Boston Scientific Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boston Scientific Main Business Overview
13.4.5 Boston Scientific Latest Developments
13.5 Sirtex Medical Limited
13.5.1 Sirtex Medical Limited Company Information
13.5.2 Sirtex Medical Limited Medical Radioactive Microspheres Product Portfolios and Specifications
13.5.3 Sirtex Medical Limited Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sirtex Medical Limited Main Business Overview
13.5.5 Sirtex Medical Limited Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Medical Radioactive Microspheres Product Portfolios and Specifications
13.6.3 Terumo Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 ABK Biomedical
13.7.1 ABK Biomedical Company Information
13.7.2 ABK Biomedical Medical Radioactive Microspheres Product Portfolios and Specifications
13.7.3 ABK Biomedical Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ABK Biomedical Main Business Overview
13.7.5 ABK Biomedical Latest Developments
13.8 AtomVie
13.8.1 AtomVie Company Information
13.8.2 AtomVie Medical Radioactive Microspheres Product Portfolios and Specifications
13.8.3 AtomVie Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AtomVie Main Business Overview
13.8.5 AtomVie Latest Developments
13.9 BWXT Medical
13.9.1 BWXT Medical Company Information
13.9.2 BWXT Medical Medical Radioactive Microspheres Product Portfolios and Specifications
13.9.3 BWXT Medical Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BWXT Medical Main Business Overview
13.9.5 BWXT Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Radioactive Microspheres Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Radioactive Microspheres by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Radioactive Microspheres by Country/Region, 2021, 2025 & 2032
2.2 Medical Radioactive Microspheres Segment by Type
2.2.1 Holmium-166 Microspheres
2.2.2 Yttrium-90 Microspheres
2.2.3 Medical Radioactive Microspheres Sales by Type
2.2.3.1 Global Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
2.2.3.2 Global Medical Radioactive Microspheres Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Medical Radioactive Microspheres Sale Price by Type (2021-2026)
2.3 Medical Radioactive Microspheres Segment by Application
2.3.1 Cancer Treatment
2.3.2 Diagnosis
2.3.3 Others
2.3.4 Medical Radioactive Microspheres Sales by Application
2.3.4.1 Global Medical Radioactive Microspheres Sale Market Share by Application (2021-2026)
2.3.4.2 Global Medical Radioactive Microspheres Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Medical Radioactive Microspheres Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Radioactive Microspheres Breakdown Data by Company
3.1.1 Global Medical Radioactive Microspheres Annual Sales by Company (2021-2026)
3.1.2 Global Medical Radioactive Microspheres Sales Market Share by Company (2021-2026)
3.2 Global Medical Radioactive Microspheres Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Radioactive Microspheres Revenue by Company (2021-2026)
3.2.2 Global Medical Radioactive Microspheres Revenue Market Share by Company (2021-2026)
3.3 Global Medical Radioactive Microspheres Sale Price by Company
3.4 Key Manufacturers Medical Radioactive Microspheres Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Radioactive Microspheres Product Location Distribution
3.4.2 Players Medical Radioactive Microspheres Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL RADIOACTIVE MICROSPHERES BY GEOGRAPHIC REGION
4.1 World Historic Medical Radioactive Microspheres Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Radioactive Microspheres Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Radioactive Microspheres Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Radioactive Microspheres Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Radioactive Microspheres Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Radioactive Microspheres Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Radioactive Microspheres Sales Growth
4.4 APAC Medical Radioactive Microspheres Sales Growth
4.5 Europe Medical Radioactive Microspheres Sales Growth
4.6 Middle East & Africa Medical Radioactive Microspheres Sales Growth
5 AMERICAS
5.1 Americas Medical Radioactive Microspheres Sales by Country
5.1.1 Americas Medical Radioactive Microspheres Sales by Country (2021-2026)
5.1.2 Americas Medical Radioactive Microspheres Revenue by Country (2021-2026)
5.2 Americas Medical Radioactive Microspheres Sales by Type (2021-2026)
5.3 Americas Medical Radioactive Microspheres Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Radioactive Microspheres Sales by Region
6.1.1 APAC Medical Radioactive Microspheres Sales by Region (2021-2026)
6.1.2 APAC Medical Radioactive Microspheres Revenue by Region (2021-2026)
6.2 APAC Medical Radioactive Microspheres Sales by Type (2021-2026)
6.3 APAC Medical Radioactive Microspheres Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Radioactive Microspheres by Country
7.1.1 Europe Medical Radioactive Microspheres Sales by Country (2021-2026)
7.1.2 Europe Medical Radioactive Microspheres Revenue by Country (2021-2026)
7.2 Europe Medical Radioactive Microspheres Sales by Type (2021-2026)
7.3 Europe Medical Radioactive Microspheres Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Radioactive Microspheres by Country
8.1.1 Middle East & Africa Medical Radioactive Microspheres Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Radioactive Microspheres Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Radioactive Microspheres Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Radioactive Microspheres Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Radioactive Microspheres
10.3 Manufacturing Process Analysis of Medical Radioactive Microspheres
10.4 Industry Chain Structure of Medical Radioactive Microspheres
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Radioactive Microspheres Distributors
11.3 Medical Radioactive Microspheres Customer
12 WORLD FORECAST REVIEW FOR MEDICAL RADIOACTIVE MICROSPHERES BY GEOGRAPHIC REGION
12.1 Global Medical Radioactive Microspheres Market Size Forecast by Region
12.1.1 Global Medical Radioactive Microspheres Forecast by Region (2027-2032)
12.1.2 Global Medical Radioactive Microspheres Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Radioactive Microspheres Forecast by Type (2027-2032)
12.7 Global Medical Radioactive Microspheres Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 New Radiomedicine Technology
13.1.1 New Radiomedicine Technology Company Information
13.1.2 New Radiomedicine Technology Medical Radioactive Microspheres Product Portfolios and Specifications
13.1.3 New Radiomedicine Technology Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 New Radiomedicine Technology Main Business Overview
13.1.5 New Radiomedicine Technology Latest Developments
13.2 Grand Pharmaceutical Group Limited
13.2.1 Grand Pharmaceutical Group Limited Company Information
13.2.2 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Product Portfolios and Specifications
13.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Grand Pharmaceutical Group Limited Main Business Overview
13.2.5 Grand Pharmaceutical Group Limited Latest Developments
13.3 YH Nu-Med
13.3.1 YH Nu-Med Company Information
13.3.2 YH Nu-Med Medical Radioactive Microspheres Product Portfolios and Specifications
13.3.3 YH Nu-Med Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 YH Nu-Med Main Business Overview
13.3.5 YH Nu-Med Latest Developments
13.4 Boston Scientific
13.4.1 Boston Scientific Company Information
13.4.2 Boston Scientific Medical Radioactive Microspheres Product Portfolios and Specifications
13.4.3 Boston Scientific Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boston Scientific Main Business Overview
13.4.5 Boston Scientific Latest Developments
13.5 Sirtex Medical Limited
13.5.1 Sirtex Medical Limited Company Information
13.5.2 Sirtex Medical Limited Medical Radioactive Microspheres Product Portfolios and Specifications
13.5.3 Sirtex Medical Limited Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Sirtex Medical Limited Main Business Overview
13.5.5 Sirtex Medical Limited Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Medical Radioactive Microspheres Product Portfolios and Specifications
13.6.3 Terumo Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 ABK Biomedical
13.7.1 ABK Biomedical Company Information
13.7.2 ABK Biomedical Medical Radioactive Microspheres Product Portfolios and Specifications
13.7.3 ABK Biomedical Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 ABK Biomedical Main Business Overview
13.7.5 ABK Biomedical Latest Developments
13.8 AtomVie
13.8.1 AtomVie Company Information
13.8.2 AtomVie Medical Radioactive Microspheres Product Portfolios and Specifications
13.8.3 AtomVie Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 AtomVie Main Business Overview
13.8.5 AtomVie Latest Developments
13.9 BWXT Medical
13.9.1 BWXT Medical Company Information
13.9.2 BWXT Medical Medical Radioactive Microspheres Product Portfolios and Specifications
13.9.3 BWXT Medical Medical Radioactive Microspheres Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BWXT Medical Main Business Overview
13.9.5 BWXT Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Radioactive Microspheres Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Radioactive Microspheres Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Holmium-166 Microspheres
Table 4. Major Players of Yttrium-90 Microspheres
Table 5. Global Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 6. Global Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Table 7. Global Medical Radioactive Microspheres Revenue by Type (2021-2026) & ($ million)
Table 8. Global Medical Radioactive Microspheres Revenue Market Share by Type (2021-2026)
Table 9. Global Medical Radioactive Microspheres Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Medical Radioactive Microspheres Sale by Application (2021-2026) & (K Dose)
Table 11. Global Medical Radioactive Microspheres Sale Market Share by Application (2021-2026)
Table 12. Global Medical Radioactive Microspheres Revenue by Application (2021-2026) & ($ million)
Table 13. Global Medical Radioactive Microspheres Revenue Market Share by Application (2021-2026)
Table 14. Global Medical Radioactive Microspheres Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Medical Radioactive Microspheres Sales by Company (2021-2026) & (K Dose)
Table 16. Global Medical Radioactive Microspheres Sales Market Share by Company (2021-2026)
Table 17. Global Medical Radioactive Microspheres Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Medical Radioactive Microspheres Revenue Market Share by Company (2021-2026)
Table 19. Global Medical Radioactive Microspheres Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Medical Radioactive Microspheres Producing Area Distribution and Sales Area
Table 21. Players Medical Radioactive Microspheres Products Offered
Table 22. Medical Radioactive Microspheres Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Medical Radioactive Microspheres Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Medical Radioactive Microspheres Sales Market Share Geographic Region (2021-2026)
Table 27. Global Medical Radioactive Microspheres Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Medical Radioactive Microspheres Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Medical Radioactive Microspheres Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Medical Radioactive Microspheres Sales Market Share by Country/Region (2021-2026)
Table 31. Global Medical Radioactive Microspheres Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Medical Radioactive Microspheres Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Medical Radioactive Microspheres Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Medical Radioactive Microspheres Sales Market Share by Country (2021-2026)
Table 35. Americas Medical Radioactive Microspheres Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Medical Radioactive Microspheres Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Medical Radioactive Microspheres Sales Market Share by Region (2021-2026)
Table 40. APAC Medical Radioactive Microspheres Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Medical Radioactive Microspheres Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Medical Radioactive Microspheres Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Medical Radioactive Microspheres Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Medical Radioactive Microspheres Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Medical Radioactive Microspheres
Table 52. Key Market Challenges & Risks of Medical Radioactive Microspheres
Table 53. Key Industry Trends of Medical Radioactive Microspheres
Table 54. Medical Radioactive Microspheres Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Medical Radioactive Microspheres Distributors List
Table 57. Medical Radioactive Microspheres Customer List
Table 58. Global Medical Radioactive Microspheres Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Medical Radioactive Microspheres Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Medical Radioactive Microspheres Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Medical Radioactive Microspheres Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Medical Radioactive Microspheres Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Medical Radioactive Microspheres Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Medical Radioactive Microspheres Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Medical Radioactive Microspheres Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Medical Radioactive Microspheres Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Medical Radioactive Microspheres Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Medical Radioactive Microspheres Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Medical Radioactive Microspheres Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Medical Radioactive Microspheres Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Medical Radioactive Microspheres Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. New Radiomedicine Technology Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 73. New Radiomedicine Technology Medical Radioactive Microspheres Product Portfolios and Specifications
Table 74. New Radiomedicine Technology Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. New Radiomedicine Technology Main Business
Table 76. New Radiomedicine Technology Latest Developments
Table 77. Grand Pharmaceutical Group Limited Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 78. Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Product Portfolios and Specifications
Table 79. Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Grand Pharmaceutical Group Limited Main Business
Table 81. Grand Pharmaceutical Group Limited Latest Developments
Table 82. YH Nu-Med Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 83. YH Nu-Med Medical Radioactive Microspheres Product Portfolios and Specifications
Table 84. YH Nu-Med Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. YH Nu-Med Main Business
Table 86. YH Nu-Med Latest Developments
Table 87. Boston Scientific Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 88. Boston Scientific Medical Radioactive Microspheres Product Portfolios and Specifications
Table 89. Boston Scientific Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Boston Scientific Main Business
Table 91. Boston Scientific Latest Developments
Table 92. Sirtex Medical Limited Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 93. Sirtex Medical Limited Medical Radioactive Microspheres Product Portfolios and Specifications
Table 94. Sirtex Medical Limited Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Sirtex Medical Limited Main Business
Table 96. Sirtex Medical Limited Latest Developments
Table 97. Terumo Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 98. Terumo Medical Radioactive Microspheres Product Portfolios and Specifications
Table 99. Terumo Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Terumo Main Business
Table 101. Terumo Latest Developments
Table 102. ABK Biomedical Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 103. ABK Biomedical Medical Radioactive Microspheres Product Portfolios and Specifications
Table 104. ABK Biomedical Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. ABK Biomedical Main Business
Table 106. ABK Biomedical Latest Developments
Table 107. AtomVie Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 108. AtomVie Medical Radioactive Microspheres Product Portfolios and Specifications
Table 109. AtomVie Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. AtomVie Main Business
Table 111. AtomVie Latest Developments
Table 112. BWXT Medical Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 113. BWXT Medical Medical Radioactive Microspheres Product Portfolios and Specifications
Table 114. BWXT Medical Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. BWXT Medical Main Business
Table 116. BWXT Medical Latest Developments
Table 1. Medical Radioactive Microspheres Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Radioactive Microspheres Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Holmium-166 Microspheres
Table 4. Major Players of Yttrium-90 Microspheres
Table 5. Global Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 6. Global Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Table 7. Global Medical Radioactive Microspheres Revenue by Type (2021-2026) & ($ million)
Table 8. Global Medical Radioactive Microspheres Revenue Market Share by Type (2021-2026)
Table 9. Global Medical Radioactive Microspheres Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Medical Radioactive Microspheres Sale by Application (2021-2026) & (K Dose)
Table 11. Global Medical Radioactive Microspheres Sale Market Share by Application (2021-2026)
Table 12. Global Medical Radioactive Microspheres Revenue by Application (2021-2026) & ($ million)
Table 13. Global Medical Radioactive Microspheres Revenue Market Share by Application (2021-2026)
Table 14. Global Medical Radioactive Microspheres Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Medical Radioactive Microspheres Sales by Company (2021-2026) & (K Dose)
Table 16. Global Medical Radioactive Microspheres Sales Market Share by Company (2021-2026)
Table 17. Global Medical Radioactive Microspheres Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Medical Radioactive Microspheres Revenue Market Share by Company (2021-2026)
Table 19. Global Medical Radioactive Microspheres Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Medical Radioactive Microspheres Producing Area Distribution and Sales Area
Table 21. Players Medical Radioactive Microspheres Products Offered
Table 22. Medical Radioactive Microspheres Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Medical Radioactive Microspheres Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Medical Radioactive Microspheres Sales Market Share Geographic Region (2021-2026)
Table 27. Global Medical Radioactive Microspheres Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Medical Radioactive Microspheres Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Medical Radioactive Microspheres Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Medical Radioactive Microspheres Sales Market Share by Country/Region (2021-2026)
Table 31. Global Medical Radioactive Microspheres Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Medical Radioactive Microspheres Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Medical Radioactive Microspheres Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Medical Radioactive Microspheres Sales Market Share by Country (2021-2026)
Table 35. Americas Medical Radioactive Microspheres Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Medical Radioactive Microspheres Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Medical Radioactive Microspheres Sales Market Share by Region (2021-2026)
Table 40. APAC Medical Radioactive Microspheres Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Medical Radioactive Microspheres Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Medical Radioactive Microspheres Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Medical Radioactive Microspheres Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Medical Radioactive Microspheres Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Medical Radioactive Microspheres Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Medical Radioactive Microspheres Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Medical Radioactive Microspheres
Table 52. Key Market Challenges & Risks of Medical Radioactive Microspheres
Table 53. Key Industry Trends of Medical Radioactive Microspheres
Table 54. Medical Radioactive Microspheres Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Medical Radioactive Microspheres Distributors List
Table 57. Medical Radioactive Microspheres Customer List
Table 58. Global Medical Radioactive Microspheres Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Medical Radioactive Microspheres Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Medical Radioactive Microspheres Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Medical Radioactive Microspheres Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Medical Radioactive Microspheres Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Medical Radioactive Microspheres Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Medical Radioactive Microspheres Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Medical Radioactive Microspheres Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Medical Radioactive Microspheres Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Medical Radioactive Microspheres Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Medical Radioactive Microspheres Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Medical Radioactive Microspheres Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Medical Radioactive Microspheres Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Medical Radioactive Microspheres Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. New Radiomedicine Technology Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 73. New Radiomedicine Technology Medical Radioactive Microspheres Product Portfolios and Specifications
Table 74. New Radiomedicine Technology Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. New Radiomedicine Technology Main Business
Table 76. New Radiomedicine Technology Latest Developments
Table 77. Grand Pharmaceutical Group Limited Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 78. Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Product Portfolios and Specifications
Table 79. Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. Grand Pharmaceutical Group Limited Main Business
Table 81. Grand Pharmaceutical Group Limited Latest Developments
Table 82. YH Nu-Med Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 83. YH Nu-Med Medical Radioactive Microspheres Product Portfolios and Specifications
Table 84. YH Nu-Med Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. YH Nu-Med Main Business
Table 86. YH Nu-Med Latest Developments
Table 87. Boston Scientific Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 88. Boston Scientific Medical Radioactive Microspheres Product Portfolios and Specifications
Table 89. Boston Scientific Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Boston Scientific Main Business
Table 91. Boston Scientific Latest Developments
Table 92. Sirtex Medical Limited Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 93. Sirtex Medical Limited Medical Radioactive Microspheres Product Portfolios and Specifications
Table 94. Sirtex Medical Limited Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 95. Sirtex Medical Limited Main Business
Table 96. Sirtex Medical Limited Latest Developments
Table 97. Terumo Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 98. Terumo Medical Radioactive Microspheres Product Portfolios and Specifications
Table 99. Terumo Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 100. Terumo Main Business
Table 101. Terumo Latest Developments
Table 102. ABK Biomedical Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 103. ABK Biomedical Medical Radioactive Microspheres Product Portfolios and Specifications
Table 104. ABK Biomedical Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 105. ABK Biomedical Main Business
Table 106. ABK Biomedical Latest Developments
Table 107. AtomVie Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 108. AtomVie Medical Radioactive Microspheres Product Portfolios and Specifications
Table 109. AtomVie Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 110. AtomVie Main Business
Table 111. AtomVie Latest Developments
Table 112. BWXT Medical Basic Information, Medical Radioactive Microspheres Manufacturing Base, Sales Area and Its Competitors
Table 113. BWXT Medical Medical Radioactive Microspheres Product Portfolios and Specifications
Table 114. BWXT Medical Medical Radioactive Microspheres Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 115. BWXT Medical Main Business
Table 116. BWXT Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Radioactive Microspheres
Figure 2. Medical Radioactive Microspheres Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Radioactive Microspheres Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Medical Radioactive Microspheres Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Radioactive Microspheres Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Radioactive Microspheres Sales Market Share by Country/Region (2025)
Figure 10. Medical Radioactive Microspheres Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Holmium-166 Microspheres
Figure 12. Product Picture of Yttrium-90 Microspheres
Figure 13. Global Medical Radioactive Microspheres Sales Market Share by Type in 2026
Figure 14. Global Medical Radioactive Microspheres Revenue Market Share by Type (2021-2026)
Figure 15. Medical Radioactive Microspheres Consumed in Cancer Treatment
Figure 16. Global Medical Radioactive Microspheres Market: Cancer Treatment (2021-2026) & (K Dose)
Figure 17. Medical Radioactive Microspheres Consumed in Diagnosis
Figure 18. Global Medical Radioactive Microspheres Market: Diagnosis (2021-2026) & (K Dose)
Figure 19. Medical Radioactive Microspheres Consumed in Others
Figure 20. Global Medical Radioactive Microspheres Market: Others (2021-2026) & (K Dose)
Figure 21. Global Medical Radioactive Microspheres Sale Market Share by Application (2025)
Figure 22. Global Medical Radioactive Microspheres Revenue Market Share by Application in 2026
Figure 23. Medical Radioactive Microspheres Sales by Company in 2026 (K Dose)
Figure 24. Global Medical Radioactive Microspheres Sales Market Share by Company in 2026
Figure 25. Medical Radioactive Microspheres Revenue by Company in 2026 ($ millions)
Figure 26. Global Medical Radioactive Microspheres Revenue Market Share by Company in 2026
Figure 27. Global Medical Radioactive Microspheres Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Medical Radioactive Microspheres Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 30. Americas Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 31. APAC Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 32. APAC Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 33. Europe Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 34. Europe Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 36. Middle East & Africa Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 37. Americas Medical Radioactive Microspheres Sales Market Share by Country in 2026
Figure 38. Americas Medical Radioactive Microspheres Revenue Market Share by Country (2021-2026)
Figure 39. Americas Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 40. Americas Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 41. United States Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Medical Radioactive Microspheres Sales Market Share by Region in 2026
Figure 46. APAC Medical Radioactive Microspheres Revenue Market Share by Region (2021-2026)
Figure 47. APAC Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 48. APAC Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 49. China Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 53. India Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Medical Radioactive Microspheres Sales Market Share by Country in 2026
Figure 57. Europe Medical Radioactive Microspheres Revenue Market Share by Country (2021-2026)
Figure 58. Europe Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 59. Europe Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 60. Germany Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 61. France Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Medical Radioactive Microspheres Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 68. Egypt Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Medical Radioactive Microspheres in 2026
Figure 74. Manufacturing Process Analysis of Medical Radioactive Microspheres
Figure 75. Industry Chain Structure of Medical Radioactive Microspheres
Figure 76. Channels of Distribution
Figure 77. Global Medical Radioactive Microspheres Sales Market Forecast by Region (2027-2032)
Figure 78. Global Medical Radioactive Microspheres Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Medical Radioactive Microspheres Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Medical Radioactive Microspheres Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Medical Radioactive Microspheres Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Medical Radioactive Microspheres Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Radioactive Microspheres
Figure 2. Medical Radioactive Microspheres Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Radioactive Microspheres Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Medical Radioactive Microspheres Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Radioactive Microspheres Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Radioactive Microspheres Sales Market Share by Country/Region (2025)
Figure 10. Medical Radioactive Microspheres Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Holmium-166 Microspheres
Figure 12. Product Picture of Yttrium-90 Microspheres
Figure 13. Global Medical Radioactive Microspheres Sales Market Share by Type in 2026
Figure 14. Global Medical Radioactive Microspheres Revenue Market Share by Type (2021-2026)
Figure 15. Medical Radioactive Microspheres Consumed in Cancer Treatment
Figure 16. Global Medical Radioactive Microspheres Market: Cancer Treatment (2021-2026) & (K Dose)
Figure 17. Medical Radioactive Microspheres Consumed in Diagnosis
Figure 18. Global Medical Radioactive Microspheres Market: Diagnosis (2021-2026) & (K Dose)
Figure 19. Medical Radioactive Microspheres Consumed in Others
Figure 20. Global Medical Radioactive Microspheres Market: Others (2021-2026) & (K Dose)
Figure 21. Global Medical Radioactive Microspheres Sale Market Share by Application (2025)
Figure 22. Global Medical Radioactive Microspheres Revenue Market Share by Application in 2026
Figure 23. Medical Radioactive Microspheres Sales by Company in 2026 (K Dose)
Figure 24. Global Medical Radioactive Microspheres Sales Market Share by Company in 2026
Figure 25. Medical Radioactive Microspheres Revenue by Company in 2026 ($ millions)
Figure 26. Global Medical Radioactive Microspheres Revenue Market Share by Company in 2026
Figure 27. Global Medical Radioactive Microspheres Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Medical Radioactive Microspheres Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 30. Americas Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 31. APAC Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 32. APAC Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 33. Europe Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 34. Europe Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Medical Radioactive Microspheres Sales 2021-2026 (K Dose)
Figure 36. Middle East & Africa Medical Radioactive Microspheres Revenue 2021-2026 ($ millions)
Figure 37. Americas Medical Radioactive Microspheres Sales Market Share by Country in 2026
Figure 38. Americas Medical Radioactive Microspheres Revenue Market Share by Country (2021-2026)
Figure 39. Americas Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 40. Americas Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 41. United States Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Medical Radioactive Microspheres Sales Market Share by Region in 2026
Figure 46. APAC Medical Radioactive Microspheres Revenue Market Share by Region (2021-2026)
Figure 47. APAC Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 48. APAC Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 49. China Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 53. India Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Medical Radioactive Microspheres Sales Market Share by Country in 2026
Figure 57. Europe Medical Radioactive Microspheres Revenue Market Share by Country (2021-2026)
Figure 58. Europe Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 59. Europe Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 60. Germany Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 61. France Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Medical Radioactive Microspheres Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Medical Radioactive Microspheres Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Medical Radioactive Microspheres Sales Market Share by Application (2021-2026)
Figure 68. Egypt Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Medical Radioactive Microspheres Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Medical Radioactive Microspheres in 2026
Figure 74. Manufacturing Process Analysis of Medical Radioactive Microspheres
Figure 75. Industry Chain Structure of Medical Radioactive Microspheres
Figure 76. Channels of Distribution
Figure 77. Global Medical Radioactive Microspheres Sales Market Forecast by Region (2027-2032)
Figure 78. Global Medical Radioactive Microspheres Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Medical Radioactive Microspheres Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Medical Radioactive Microspheres Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Medical Radioactive Microspheres Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Medical Radioactive Microspheres Revenue Market Share Forecast by Application (2027-2032)
